<DOC>
	<DOCNO>NCT02635412</DOCNO>
	<brief_summary>This randomize controlled trial investigate optimal timing delivery clinically stable woman suspect morbidly adherent placenta .</brief_summary>
	<brief_title>Delivery Timing Morbidly Adherent Placentas : Randomized , Controlled Trial</brief_title>
	<detailed_description>This randomize controlled trial investigate optimal timing delivery clinically stable woman suspect morbidly adherent placenta dispositioned scheduled delivery . The primary outcome assess compare composite neonatal morbidity composite maternal morbidity two group ( delivery 34 versus 36 week gestational age ) .</detailed_description>
	<mesh_term>Placenta Accreta</mesh_term>
	<criteria>Women monographically morbidly adherent placenta without placenta previa . Scheduled delivery via cesarean hysterectomy Delivery plan prior 36 week ( e.g . nonreassuring fetal status , preterm labor , severe preeclampsia , medical/fetal indication delivery determine manage physician ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Placenta</keyword>
	<keyword>Accreta</keyword>
	<keyword>Morbidly</keyword>
	<keyword>Adherent Placenta</keyword>
</DOC>